AI Verdict
KAPA has stronger fundamentals based on our AI analysis.
KAYS vs KAPA Fundamental Comparison
| Metric | KAYS | KAPA |
|---|---|---|
| Revenue | $22,557.0 | N/A |
| Net Income | $-12.7M | $-5.4M |
| Net Margin | -56,290.2% | N/A |
| ROE | N/A | -85.9% |
| ROA | -6,369.1% | -83.3% |
| Current Ratio | 0.04x | 27.07x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.16 | $-0.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KAYS vs KAPA: Frequently Asked Questions
Is KAYS or KAPA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KAPA has stronger fundamentals. KAYS is rated STRONG SELL (98% confidence) while KAPA is rated SELL (85% confidence). This is not investment advice.
How does KAYS compare to KAPA fundamentally?
Kaya Holdings, Inc. has ROE of N/A vs Kairos Pharma, LTD.'s -85.9%. Net margins are -56,290.2% vs N/A respectively.
Which stock pays higher dividends, KAYS or KAPA?
KAYS has a dividend yield of N/A or no dividend while KAPA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KAYS or KAPA for long term?
For long-term investing, consider that KAYS has STRONG SELL rating with 98% confidence, while KAPA has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KAYS vs KAPA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KAYS vs KAPA, the AI consensus favors KAPA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.